In Moldova, the pregnant women living with hiv antiretroviral therapy coverage for pmtct stands at 96%, reflecting an increase of 9% (10.3%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Moldova
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Moldova
PMTCT antiretroviral therapy coverage
More indicators for Moldova
Male unintentional poisoning
7.7
-0.5
(2019)
Female wasting in children
1.8%
-3.9%
(2012)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar355
+intl dollar84
(2021)
Birth registration
99.6%
+1.6%
(2012)
Contraceptive modern method prevalence
43.9%
+1.6%
(2020)
Moldova PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 96% | +9% |
| 2021 | 87% | +9% |
| 2020 | 78% | -11% |
| 2019 | 89% | +9% |
| 2018 | 80% | -9% |
| 2017 | 89% | +10% |
| 2016 | 79% | +2% |
| 2015 | 77% | +5% |
| 2014 | 72% | +8% |
| 2013 | 64% | -3% |
| 2012 | 67% | +2% |
| 2011 | 65% | -3% |
| 2010 | 68% | +6% |
| 2009 | 62% | -15% |
| 2008 | 77% | +31% |
| 2007 | 46% | +5% |
| 2006 | 41% | +17% |
| 2005 | 24% | +2% |
| 2004 | 22% | +19% |
| 2003 | 3% | +3% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |